Clinical Trial Update: Venetoclax Basket Trial for High Risk Hematologic Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 Venetoclax basket trial across multiple high-risk hematologic malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Leukemia of Ambiguous Lineage
• Lymphoblastic Lymphoma
• Myelodysplastic Syndromes

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: Andrew E. Place, MD | Conditions: Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary | Phase 1 | Status: RECRUITING